Global and Japan Tourette Syndrome Drug Market Insights, Forecast to 2027
Table of Contents1 Study Coverage
1.1 Tourette Syndrome Drug Product Introduction
1.2 Market by Type
1.2.1 Global Tourette Syndrome Drug Market Size Growth Rate by Type
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Market by Application
1.3.1 Global Tourette Syndrome Drug Market Size Growth Rate by Application
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Tourette Syndrome Drug Market Size, Estimates and Forecasts
2.1.1 Global Tourette Syndrome Drug Revenue 2016-2027
2.1.2 Global Tourette Syndrome Drug Sales 2016-2027
2.2 Global Tourette Syndrome Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Tourette Syndrome Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Tourette Syndrome Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Tourette Syndrome Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Tourette Syndrome Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Tourette Syndrome Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Tourette Syndrome Drug Revenue Forecast by Region (2022-2027)
3 Global Tourette Syndrome Drug Competitor Landscape by Players
3.1 Global Top Tourette Syndrome Drug Manufacturers by Sales
3.1.1 Global Tourette Syndrome Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Tourette Syndrome Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Tourette Syndrome Drug Manufacturers by Revenue
3.2.1 Key Tourette Syndrome Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Tourette Syndrome Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Tourette Syndrome Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Tourette Syndrome Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Tourette Syndrome Drug Revenue in 2020
3.2.6 Global Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Tourette Syndrome Drug Price by Manufacturers
3.4 Global Tourette Syndrome Drug Manufacturing Base Distribution, Product Types
3.4.1 Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tourette Syndrome Drug Product Type
3.4.3 Date of International Manufacturers Enter into Tourette Syndrome Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Tourette Syndrome Drug Market Size by Type (2016-2021)
4.1.1 Global Tourette Syndrome Drug Sales by Type (2016-2021)
4.1.2 Global Tourette Syndrome Drug Revenue by Type (2016-2021)
4.1.3 Tourette Syndrome Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Tourette Syndrome Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Tourette Syndrome Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Tourette Syndrome Drug Revenue Forecast by Type (2022-2027)
4.2.3 Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Tourette Syndrome Drug Market Size by Application (2016-2021)
5.1.1 Global Tourette Syndrome Drug Sales by Application (2016-2021)
5.1.2 Global Tourette Syndrome Drug Revenue by Application (2016-2021)
5.1.3 Tourette Syndrome Drug Price by Application (2016-2021)
5.2 Tourette Syndrome Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Tourette Syndrome Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Tourette Syndrome Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Tourette Syndrome Drug Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Tourette Syndrome Drug Market Size YoY Growth 2016-2027
6.1.1 Japan Tourette Syndrome Drug Sales YoY Growth 2016-2027
6.1.2 Japan Tourette Syndrome Drug Revenue YoY Growth 2016-2027
6.1.3 Japan Tourette Syndrome Drug Market Share in Global Market 2016-2027
6.2 Japan Tourette Syndrome Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Tourette Syndrome Drug Players by Sales (2016-2021)
6.2.2 Japan Top Tourette Syndrome Drug Players by Revenue (2016-2021)
6.3 Japan Tourette Syndrome Drug Historic Market Review by Type (2016-2021)
6.3.1 Japan Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
6.3.2 Japan Tourette Syndrome Drug Revenue Market Share by Type (2016-2021)
6.3.3 Japan Tourette Syndrome Drug Price by Type (2016-2021)
6.4 Japan Tourette Syndrome Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Tourette Syndrome Drug Sales Forecast by Type (2022-2027)
6.4.2 Japan Tourette Syndrome Drug Revenue Forecast by Type (2022-2027)
6.4.3 Japan Tourette Syndrome Drug Price Forecast by Type (2022-2027)
6.5 Japan Tourette Syndrome Drug Historic Market Review by Application (2016-2021)
6.5.1 Japan Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
6.5.2 Japan Tourette Syndrome Drug Revenue Market Share by Application (2016-2021)
6.5.3 Japan Tourette Syndrome Drug Price by Application (2016-2021)
6.6 Japan Tourette Syndrome Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Tourette Syndrome Drug Sales Forecast by Application (2022-2027)
6.6.2 Japan Tourette Syndrome Drug Revenue Forecast by Application (2022-2027)
6.6.3 Japan Tourette Syndrome Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Tourette Syndrome Drug Market Size YoY Growth 2016-2027
7.2 North America Tourette Syndrome Drug Market Facts & Figures by Country
7.2.1 North America Tourette Syndrome Drug Sales by Country (2016-2021)
7.2.2 North America Tourette Syndrome Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Tourette Syndrome Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Tourette Syndrome Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Tourette Syndrome Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Tourette Syndrome Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Tourette Syndrome Drug Market Size YoY Growth 2016-2027
9.2 Europe Tourette Syndrome Drug Market Facts & Figures by Country
9.2.1 Europe Tourette Syndrome Drug Sales by Country (2016-2021)
9.2.2 Europe Tourette Syndrome Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Tourette Syndrome Drug Market Size YoY Growth 2016-2027
10.2 Latin America Tourette Syndrome Drug Market Facts & Figures by Country
10.2.1 Latin America Tourette Syndrome Drug Sales by Country (2016-2021)
10.2.2 Latin America Tourette Syndrome Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Tourette Syndrome Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Tourette Syndrome Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Tourette Syndrome Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Tourette Syndrome Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Abide Therapeutics Inc
12.1.1 Abide Therapeutics Inc Corporation Information
12.1.2 Abide Therapeutics Inc Description and Business Overview
12.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
12.1.5 Abide Therapeutics Inc Recent Development
12.2 Catalyst Pharmaceuticals Inc
12.2.1 Catalyst Pharmaceuticals Inc Corporation Information
12.2.2 Catalyst Pharmaceuticals Inc Description and Business Overview
12.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.2.5 Catalyst Pharmaceuticals Inc Recent Development
12.3 Neurocrine Biosciences Inc
12.3.1 Neurocrine Biosciences Inc Corporation Information
12.3.2 Neurocrine Biosciences Inc Description and Business Overview
12.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Neurocrine Biosciences Inc Tourette Syndrome Drug Products Offered
12.3.5 Neurocrine Biosciences Inc Recent Development
12.4 Psyadon Pharmaceuticals Inc
12.4.1 Psyadon Pharmaceuticals Inc Corporation Information
12.4.2 Psyadon Pharmaceuticals Inc Description and Business Overview
12.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.4.5 Psyadon Pharmaceuticals Inc Recent Development
12.5 Reviva Pharmaceuticals Inc
12.5.1 Reviva Pharmaceuticals Inc Corporation Information
12.5.2 Reviva Pharmaceuticals Inc Description and Business Overview
12.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Products Offered
12.5.5 Reviva Pharmaceuticals Inc Recent Development
12.6 Synchroneuron Inc
12.6.1 Synchroneuron Inc Corporation Information
12.6.2 Synchroneuron Inc Description and Business Overview
12.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Synchroneuron Inc Tourette Syndrome Drug Products Offered
12.6.5 Synchroneuron Inc Recent Development
12.7 Teva Pharmaceutical Industries Ltd
12.7.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Products Offered
12.7.5 Teva Pharmaceutical Industries Ltd Recent Development
12.8 Therapix Biosciences Ltd
12.8.1 Therapix Biosciences Ltd Corporation Information
12.8.2 Therapix Biosciences Ltd Description and Business Overview
12.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Therapix Biosciences Ltd Tourette Syndrome Drug Products Offered
12.8.5 Therapix Biosciences Ltd Recent Development
12.11 Abide Therapeutics Inc
12.11.1 Abide Therapeutics Inc Corporation Information
12.11.2 Abide Therapeutics Inc Description and Business Overview
12.11.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Abide Therapeutics Inc Tourette Syndrome Drug Products Offered
12.11.5 Abide Therapeutics Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Tourette Syndrome Drug Industry Trends
13.2 Tourette Syndrome Drug Market Drivers
13.3 Tourette Syndrome Drug Market Challenges
13.4 Tourette Syndrome Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tourette Syndrome Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of TablesTable 1. Global Tourette Syndrome Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of AZD-5213
Table 3. Major Manufacturers of CPP-115
Table 4. Major Manufacturers of Dutetrabenazine ER
Table 5. Major Manufacturers of Ecopipam Hydrochloride
Table 6. Major Manufacturers of Others
Table 7. Global Tourette Syndrome Drug Market Size Growth Rate by Application (2021-2027) & (K Pcs)
Table 8. Global Tourette Syndrome Drug Market Size by Region (K Pcs) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Tourette Syndrome Drug Sales by Regions (2016-2021) & (K Pcs)
Table 10. Global Tourette Syndrome Drug Sales Market Share by Regions (2016-2021)
Table 11. Global Tourette Syndrome Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Tourette Syndrome Drug Sales Forecast by Region (2022-2027) & (K Pcs)
Table 13. Global Tourette Syndrome Drug Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Tourette Syndrome Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Tourette Syndrome Drug Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Tourette Syndrome Drug Sales by Manufacturers (2016-2021) (K Pcs)
Table 17. Global Tourette Syndrome Drug Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Tourette Syndrome Drug Manufacturers by Revenue (US$ Million) in 2020
Table 19. Tourette Syndrome Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Tourette Syndrome Drug Revenue Share by Manufacturers (2016-2021)
Table 21. Global Tourette Syndrome Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Tourette Syndrome Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tourette Syndrome Drug as of 2020)
Table 23. Key Manufacturers Tourette Syndrome Drug Price (2016-2021) (USD/Pcs)
Table 24. Tourette Syndrome Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Tourette Syndrome Drug Product Type
Table 26. Date of International Manufacturers Enter into Tourette Syndrome Drug Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Tourette Syndrome Drug Sales by Type (2016-2021) (K Pcs)
Table 29. Global Tourette Syndrome Drug Sales Share by Type (2016-2021)
Table 30. Global Tourette Syndrome Drug Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Tourette Syndrome Drug Revenue Share by Type (2016-2021)
Table 32. Tourette Syndrome Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Pcs)
Table 33. Global Tourette Syndrome Drug Sales Forecast by Type (2022-2027) & (K Pcs)
Table 34. Global Tourette Syndrome Drug Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Tourette Syndrome Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Tourette Syndrome Drug Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Pcs)
Table 38. Global Tourette Syndrome Drug Sales by Application (2016-2021) (K Pcs)
Table 39. Global Tourette Syndrome Drug Sales Share by Application (2016-2021)
Table 40. Global Tourette Syndrome Drug Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Tourette Syndrome Drug Revenue Share by Application (2016-2021)
Table 42. Tourette Syndrome Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Pcs)
Table 43. Global Tourette Syndrome Drug Sales Forecast by Application (2022-2027) & (K Pcs)
Table 44. Global Tourette Syndrome Drug Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Tourette Syndrome Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Tourette Syndrome Drug Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Tourette Syndrome Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Pcs)
Table 48. Japan Tourette Syndrome Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 49. Japan Tourette Syndrome Drug Sales Share by Company (2016-2021)
Table 50. Japan Tourette Syndrome Drug Revenue (US$ Million) by Company (2016-2021)
Table 51. Japan Tourette Syndrome Drug Revenue Share by Company (2016-2021)
Table 52. Japan Tourette Syndrome Drug Sales (K Pcs) by Type (2016-2021)
Table 53. Japan Tourette Syndrome Drug Sales Share by Type (2016-2021)
Table 54. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. Japan Tourette Syndrome Drug Price (USD/Pcs) by Type (2016-2021)
Table 56. Japan Tourette Syndrome Drug Sales (K Pcs) by Type (2022-2027)
Table 57. Japan Tourette Syndrome Drug Sales Share by Type (2022-2027)
Table 58. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. Japan Tourette Syndrome Drug Revenue Share by Type (2022-2027)
Table 60. Japan Tourette Syndrome Drug Price (USD/Pcs) by Type (2022-2027)
Table 61. Japan Tourette Syndrome Drug Sales (K Pcs) by Application (2016-2021)
Table 62. Japan Tourette Syndrome Drug Sales Share by Application (2016-2021)
Table 63. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. Japan Tourette Syndrome Drug Price (USD/Pcs) by Application (2016-2021)
Table 65. Japan Tourette Syndrome Drug Sales (K Pcs) by Application (2022-2027)
Table 66. Japan Tourette Syndrome Drug Sales Share by Application (2022-2027)
Table 67. Japan Tourette Syndrome Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. Japan Tourette Syndrome Drug Revenue Share by Application (2022-2027)
Table 69. Japan Tourette Syndrome Drug Price (USD/Pcs) by Application (2022-2027)
Table 70. North America Tourette Syndrome Drug Sales by Country (2016-2021) & (K Pcs)
Table 71. North America Tourette Syndrome Drug Sales Market Share by Country (2016-2021)
Table 72. North America Tourette Syndrome Drug Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Tourette Syndrome Drug Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Tourette Syndrome Drug Sales by Region (2016-2021) & (K Pcs)
Table 75. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Tourette Syndrome Drug Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region (2016-2021)
Table 78. Europe Tourette Syndrome Drug Sales by Country (2016-2021) & (K Pcs)
Table 79. Europe Tourette Syndrome Drug Sales Market Share by Country (2016-2021)
Table 80. Europe Tourette Syndrome Drug Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Tourette Syndrome Drug Revenue Market Share by Country (2016-2021)
Table 82. Latin America Tourette Syndrome Drug Sales by Country (2016-2021) & (K Pcs)
Table 83. Latin America Tourette Syndrome Drug Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Tourette Syndrome Drug Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Tourette Syndrome Drug Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Tourette Syndrome Drug Sales by Country (2016-2021) & (K Pcs)
Table 87. Middle East and Africa Tourette Syndrome Drug Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Tourette Syndrome Drug Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Tourette Syndrome Drug Revenue Market Share by Country (2016-2021)
Table 90. Abide Therapeutics Inc Corporation Information
Table 91. Abide Therapeutics Inc Description and Business Overview
Table 92. Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 93. Abide Therapeutics Inc Tourette Syndrome Drug Product
Table 94. Abide Therapeutics Inc Recent Development
Table 95. Catalyst Pharmaceuticals Inc Corporation Information
Table 96. Catalyst Pharmaceuticals Inc Description and Business Overview
Table 97. Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 98. Catalyst Pharmaceuticals Inc Product
Table 99. Catalyst Pharmaceuticals Inc Recent Development
Table 100. Neurocrine Biosciences Inc Corporation Information
Table 101. Neurocrine Biosciences Inc Description and Business Overview
Table 102. Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 103. Neurocrine Biosciences Inc Product
Table 104. Neurocrine Biosciences Inc Recent Development
Table 105. Psyadon Pharmaceuticals Inc Corporation Information
Table 106. Psyadon Pharmaceuticals Inc Description and Business Overview
Table 107. Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 108. Psyadon Pharmaceuticals Inc Product
Table 109. Psyadon Pharmaceuticals Inc Recent Development
Table 110. Reviva Pharmaceuticals Inc Corporation Information
Table 111. Reviva Pharmaceuticals Inc Description and Business Overview
Table 112. Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Reviva Pharmaceuticals Inc Product
Table 114. Reviva Pharmaceuticals Inc Recent Development
Table 115. Synchroneuron Inc Corporation Information
Table 116. Synchroneuron Inc Description and Business Overview
Table 117. Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Synchroneuron Inc Product
Table 119. Synchroneuron Inc Recent Development
Table 120. Teva Pharmaceutical Industries Ltd Corporation Information
Table 121. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 122. Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Teva Pharmaceutical Industries Ltd Product
Table 124. Teva Pharmaceutical Industries Ltd Recent Development
Table 125. Therapix Biosciences Ltd Corporation Information
Table 126. Therapix Biosciences Ltd Description and Business Overview
Table 127. Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Therapix Biosciences Ltd Product
Table 129. Therapix Biosciences Ltd Recent Development
Table 130. Tourette Syndrome Drug Market Trends
Table 131. Tourette Syndrome Drug Market Drivers
Table 132. Tourette Syndrome Drug Market Challenges
Table 133. Tourette Syndrome Drug Market Restraints
Table 134. Tourette Syndrome Drug Customers List
Table 135. Tourette Syndrome Drug Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of FiguresFigure 1. Tourette Syndrome Drug Product Picture
Figure 2. Global Tourette Syndrome Drug Sales Market Share by Type in 2020 & 2027
Figure 3. AZD-5213 Product Picture
Figure 4. CPP-115 Product Picture
Figure 5. Dutetrabenazine ER Product Picture
Figure 6. Ecopipam Hydrochloride Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tourette Syndrome Drug Sales Market Share by Application in 2020 & 2027
Figure 9. Research Center
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Tourette Syndrome Drug Report Years Considered
Figure 14. Global Tourette Syndrome Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Tourette Syndrome Drug Market Size 2016-2027 (US$ Million)
Figure 16. Global Tourette Syndrome Drug Sales 2016-2027 (K Pcs)
Figure 17. Global Tourette Syndrome Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Tourette Syndrome Drug Sales Market Share by Region (2016-2021)
Figure 19. Global Tourette Syndrome Drug Sales Market Share by Region in 2020
Figure 20. Global Tourette Syndrome Drug Revenue Market Share by Region (2016-2021)
Figure 21. Global Tourette Syndrome Drug Revenue Market Share by Region in 2020
Figure 22. Global Tourette Syndrome Drug Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Tourette Syndrome Drug Revenue in 2020
Figure 24. Tourette Syndrome Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Tourette Syndrome Drug Sales Market Share by Type (2016-2021)
Figure 26. Global Tourette Syndrome Drug Sales Market Share by Type in 2020
Figure 27. Global Tourette Syndrome Drug Revenue Market Share by Type (2016-2021)
Figure 28. Global Tourette Syndrome Drug Revenue Market Share by Type in 2020
Figure 29. Global Tourette Syndrome Drug Sales Market Share by Application (2016-2021)
Figure 30. Global Tourette Syndrome Drug Sales Market Share by Application in 2020
Figure 31. Global Tourette Syndrome Drug Revenue Market Share by Application (2016-2021)
Figure 32. Global Tourette Syndrome Drug Revenue Market Share by Application in 2020
Figure 33. Japan Tourette Syndrome Drug Sales Growth Rate 2016-2027 (K Pcs)
Figure 34. Japan Tourette Syndrome Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. Japan Tourette Syndrome Drug Market Share in Global Market 2016-2027
Figure 36. Japan 5 and 10 Largest Tourette Syndrome Drug Players Market Share by Revenue in Tourette Syndrome Drug in 2020
Figure 37. Japan Tourette Syndrome Drug Revenue Share by Type (2016-2021)
Figure 38. Japan Tourette Syndrome Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 39. Japan Tourette Syndrome Drug Revenue Share by Application (2016-2021)
Figure 40. Japan Tourette Syndrome Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Tourette Syndrome Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 42. North America Tourette Syndrome Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Tourette Syndrome Drug Sales Market Share by Country in 2020
Figure 44. North America Tourette Syndrome Drug Revenue Market Share by Country in 2020
Figure 45. U.S. Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 46. U.S. Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 48. Canada Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Tourette Syndrome Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 50. Europe Tourette Syndrome Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Tourette Syndrome Drug Sales Market Share by Country in 2020
Figure 52. Europe Tourette Syndrome Drug Revenue Market Share by Country in 2020
Figure 53. Germany Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 54. Germany Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 56. France Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. U.K. Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 58. U.K. Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 60. Italy Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 62. Russia Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Tourette Syndrome Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 64. Asia Pacific Tourette Syndrome Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Tourette Syndrome Drug Sales Market Share by Region in 2020
Figure 66. Asia Pacific Tourette Syndrome Drug Revenue Market Share by Region in 2020
Figure 67. China Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 68. China Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 70. Japan Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 72. South Korea Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 74. India Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 76. Australia Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Taiwan Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 78. Taiwan Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Indonesia Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 80. Indonesia Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Thailand Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 82. Thailand Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Malaysia Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 84. Malaysia Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Philippines Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 86. Philippines Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Vietnam Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 88. Vietnam Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Latin America Tourette Syndrome Drug Sales Growth Rate 2016-2021 (K Pcs)
Figure 90. Latin America Tourette Syndrome Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 91. Latin America Tourette Syndrome Drug Sales Market Share by Country in 2020
Figure 92. Latin America Tourette Syndrome Drug Revenue Market Share by Country in 2020
Figure 93. Mexico Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 94. Mexico Tourette Syndrome Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Brazil Tourette Syndrome Drug Sales Growth Rate (2016-2021) (K Pcs)
Figure 96. Braz